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Promotion  of  good  practice  guidelines  is  clearly
a laudable pursuit for any aspect of scientiﬁc
endeavor; not least in the area of patient-reported
outcome (PRO) instrument adaptation, where
extemporary approaches to translation are com-
monplace. Nevertheless, what Wild and colleagues
have produced are not so much “principles of good
practice” as a synthesis of the opinions of a number
of organizations on how to translate PRO measures
[1]. Indeed, in several instances more than one opin-
ion is expressed. No scientiﬁc evidence is provided
to support these opinions and the suggested meth-
odology falls short of including a meaningful test of
the quality of the translations produced.
Rather than reviewing all published translation
recommendations as reported, the authors have
neglected a considerable body of literature that uti-
lizes a rather different methodology to the forward–
backward translation approach [2–4]. This is the
two-panel approach that employs professional and
lay panel meetings rather than back translation.
This approach has been used in the development of
20 disease-speciﬁc quality of life measures in up to
30 languages [5].
Indeed it is not clear how the concept of back
translation came into existence. With the need for
standardized PROs for use in multinational studies
it was probably recognized that there was a require-
ment for determining the quality of the target ver-
sion by some sort of “scientiﬁc” method. Despite
this need, back translation has no clear scientiﬁc
basis and its use casts doubts on the ability of trans-
lators. One could question what right the test-
developers or adaptors have to question the
competence of members of another profession. If the
translation is good, the back translation may look
nothing like the source questionnaire. Consequently,
little information of any value will be obtained from
a back translation, whereas many misleading
impressions may result. A classic example of the
problem with relying on back translation was pro-
vided by Fukuhara and colleagues [6] whose attempt
to translate the SF-36 into Japanese failed and they
had to resort to employing the equivalent of a lay
translation panel (as used by the European Group
for Quality of Life Assessment and Health Meas-
urement [2,3]) to overcome the problems. The
researchers concluded that adherence to the Inter-
national Quality of Life Assessment project guide-
lines did not ensure an adequate translation,
reﬂecting the linguistic and cultural differences
between Japan and the United States. The answer
must be to produce quality in the translation, in
addition to checking it a posteriori [4]. Producing
quality requires checking and rechecking through-
out the process, as well as after it, to see if the instru-
ment functions as required with “real” people.
It should also be noted that translation is just one
step in the production of new language versions of
an instrument. Full adaptation requires that the
scaling and psychometric properties of the new lan-
guage version are also assessed [4]. It is indeed bad
practice to simply assume that a translated version
shares the same psychometric properties as the orig-
inal source version. It may be that this is an area still
to be addressed by the working group, although this
seems unlikely as the guidelines they reviewed do
not include such quality controls and such valida-
tion is rarely reported.
It is here that Wild et al.’s proposed methodology
is particularly weak. Virtually no attempt is made to
validate the process—a fundamental requirement of
any research. Cognitive debrieﬁng interviews are
generally conducted with as few as ﬁve patients and
no other form of assessment is proposed. Given that
PRO measures are sometimes written by test-devel-
opers rather than being derived from patients, this is
hardly an adequate test of even face and content
validity. No recommendation is made for retesting
scalability, reproducibility, construct validity or
equivalence to the source measure. It is essential (at
a minimum) to show that language adaptations are
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reproducible and valid in themselves. Such retesting
is routinely conducted in the adaptation of some
instruments. For example, all adaptations of needs-
based quality of life measures are formally tested for
unidimensionality, reproducibility and construct
validity [see for example; 7–9].
It is now also possible to test whether adapted
measures are equivalent to the original source ver-
sion by application of item response theory [10].
The probability of being able to afﬁrm a PRO item
for patients at the same level of ability (or, e.g., with
the same level of quality of life) should remain the
same across language versions. Thus, comparability
of language versions is dependent on both the con-
ceptual equivalence of items and also on the con-
struct value equivalence of those items. An item
may cover the same concept in both source and tar-
get language but it may well be valued differently in
each culture. Assessment of such “differential item
functioning” yields crucial information about the
equivalence of language versions and provides val-
uable information on the validity of pooling data
across countries; an issue which is of particular
importance for multicenter clinical trials [11].
But why should it be expected that well trans-
lated questionnaires will be equivalent across lan-
guages? A language is a speciﬁc way of putting life
into words; and words change with their context.
They generate representations that may be universal
or culture-speciﬁc. Therefore, it is more appropriate
to consider the process as one of adaptation rather
than translation [4]. Extending this idea, it is likely
that in the relatively near future it will be recognized
that translating source measures into new languages
is both inefﬁcient and scientiﬁcally unhelpful.
Where carefully constructed unidimensional scales
are produced based on a coherent measurement
model it is possible to develop language versions
that consist of items that are speciﬁc to, and work
well in, each country. These need not be the same
items—although it is likely that there will be items
in common across languages. The aim would be to
have a set of items that had the same value in each
language (derived from the application of item
response theory). Only then would construct equiv-
alence be guaranteed.
Although such work is currently being piloted it
is likely to be some time before such a radical (but
necessary) development would be acceptable to
health authorities. In the meantime, how is it pos-
sible to determine the most appropriate method of
translating PRO measures? A study is currently
underway to compare two Swedish versions of the
Rheumatoid Arthritis Quality of Life (RAQoL)
questionnaire [12,13]. The opportunity arose to
make the comparison due to the unauthorized
translation and publication of a Swedish version of
the RAQoL [14,15] that occurred simultaneously
with the production of an authorized adaptation.
The former applied back translation and the latter
the two-panel methodology to produce the transla-
tions. Blind assessments of the ﬁnal item transla-
tions are being made by Swedish bilinguals and
patients with rheumatoid arthritis (RA). A test-
retest survey with RA patients is planned to com-
pare psychometric properties of the two versions
and Rasch analysis will be used to compare the scal-
ing properties of each version to the source ques-
tionnaire. Initial results from the study indicate that
items translated using the two-panel method are
statistically signiﬁcantly preferred to those based on
back translation. This is initial evidence that the
two-panel method has better face validity than the
use of back translation.
We strongly feel that it is essential to collect evi-
dence before asserting that back translation, an
untested method—however, widely implemented—
represents “principles of good practice.”
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